Role of the region 23-28 in Aβ fibril formation: Insights from simulations of the monomers and dimers of Alzheimer's peptides Aβ40 and Aβ42

Current Alzheimer Research

Volumn 5, Issue 3, 2008, Pages 244-250

  Melquiond, Adrien ^a   Dong, Xiao ^a,b   Mousseau, Normand ^b   Derreumaux, Philippe ^a  

^a INST DE BIOLOGIE PHYSICO CHIMIQUE   (France)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Alzheimer; Amyloid beta; Coarse grained model; Monomer and dimer; Protein aggregation; Simulations; Structures; Thermodynamics

Indexed keywords

AMINO ACID; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; DIMER; MONOMER;

ALZHEIMER DISEASE; BETA SHEET; COMPUTER SIMULATION; HYDROPHOBICITY; NEUROTOXICITY; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN STRUCTURE; REVIEW;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; HUMANS; PEPTIDE FRAGMENTS; PROTEIN FOLDING; PROTEIN STRUCTURE, SECONDARY;

EID: 45249089694     PISSN: 15672050     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720508784533330     Document Type: Review

References (72)

1. Selkoe DJ. The cell biology of β-amyloid precursor protein, presenilin in Alzheimer's disease. Trends Cell Biol 8: 447-53 (1998).
2. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325: 733-6 (1987).
3. Hou L, Shao H, Zhang Y, Li H, Menon NK, Neuhaus EB, et al. Solution NMR studies of the Aβ(1-40), Aβ(1-42) peptides establish that the Met35 oxidation state affects the mechanism of amyloid formation. J Am Chem Soc 126: 1992-2005 (2004).
4. Danielsson J, Jarvet J, Damberg P, Graslund A. The Alzheimer beta-peptide shows temperature-dependent transitions between left-handed 3-helix, beta-strand, random coil secondary structures. FEBS J 272: 3938-49 (2005).
5. Lesne S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, et al. A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440: 352-7 (2006).
6. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416: 535-9 (2002).
7. Losic D, Martin LL, Mechler A, Aguilar MI, Small DH. High resolution scanning tunnelling microscopy of the beta-amyloid protein (Aβ1-40) of Alzheimer's disease suggests a novel mechanism of oligomer assembly. J Struct Biol 155: 104-10 (2006).
8. Garzon-Rodriguez W, Vega A, Sepulveda-Becerra M, Milton S, Johnson DA, Yatsimirsky AK, et al. A conformation change in the carboxyl terminus of Alzheimer's Aβ(1-40) accompanies the transition from dimer to fibril as revealed by fluorescence quenching analysis. J Biol Chem 275: 22645-9 (2000).
9. Chen YR, Glabe CG. Distinct early folding, aggregation properties of Alzheimer amyloid-beta peptides Aβ40, Aβ42: stable trimer or tetramer formation by Aβ42. J Biol Chem 281: 24414-22 (2006).
10. Bitan G, Vollers SS, Teplow DB. Elucidation of primary structure elements controlling early amyloid beta-protein oligomerization. J Biol Chem 278: 34882-9 (2003).
11. Huang TH, Yang DS, Plaskos NP, Go S, Yip CM, Fraser PE, et al. Structural studies of soluble oligomers of the Alzheimer beta-amyloid peptide. J Mol Biol 297: 73-87 (2000).
12. Lazo ND, Grant MA, Condron MC, Rigby AC, Teplow DB. On the nucleation of amyloid beta-protein monomer folding. Protein Sci 14: 1581-96 (2005).
13. Sciarretta KL, Gordon DJ, Petkova AT, Tycko R, Meredith SC. Aβ40-Lactam(D23/K28) models a conformation highly favorable for nucleation of amyloid. Biochemistry 44: 6003-14 (2005).
14. Petkova AT, Ishii Y, Balbach JJ, Antzutkin ON, Leapman RD, Delaglio F, et al. A structural model for Alzheimer's beta-amyloid fibrils based on experimental constraints from solid state NMR. Proc Natl Acad Sci USA 99: 16742-7 (2002).
15. Ma B, Nussinov R. Simulations as analytical tools to understand protein aggregation, predict amyloid conformation. Curr Opin Chem Biol 10: 445-52 (2006).
16. Luhrs T, Ritter C, Adrian M, Riek-Loher D, Bohrmann B, Dobeli H, et al 3D structure of Alzheimer's amyloid-β(1-42) fibrils. Proc Natl Acad Sci USA 102: 17342-7 (2005).
17. Petkova AT, Yau WM, Tycko R. Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils. Biochemistry 45: 498-512 (2006).
18. Mousseau N, Derreumaux P. Exploring the early steps of amyloid peptide aggregation by computers. Acc Chem Res 38: 885-91 (2005).
19. Urbanc B, Cruz L, Teplow DB, Stanley HE. Computer simulations of Alzheimer's amyloid beta-protein folding, assembly. Curr Alzheimer Res 3: 493-504 (2006).
20. Hall CK, Wagoner VA. Computational approaches to fibril structure, formation. Methods Enzymol 412: 338-65 (2006).
21. Colombo G, Soto P, Gazit E. Peptide self-assembly at the nanoscale: a challenging target for computational, experimental biotechnology. Trends Biotechnol 25: 211-8 (2007).
22. Wei G, Mousseau N, Derreumaux P. Computational simulation of the early steps of protein aggregation. Prion 1: 1-6 (2007).
23. Derreumaux P. Ab initio polypeptide structure prediction. Theor Chem Acc 104: 1-6 (2000).
24. Cruz L, Urbanc B, Borreguero JM, Lazo ND, Teplow DB, Stanley HE. Solvent, mutation effects on the nucleation of amyloid beta-protein folding. Proc Natl Acad Sci USA 102: 18258-63 (2005).
25. Baumketner A, Bernstein SL, Wyttenbach T, Lazo ND, Teplow DB, Bowers MT, et al. Structure of the 21-30 fragment of amyloid beta-protein. Protein Sci 15: 1239-47 (2006).
26. Borreguero JM, Urbanc B, Lazo ND, Buldyrev SV, Teplow DB, Stanley HE. Folding events in the 21-30 region of amyloid beta-protein (Aβ) studied in silico. Proc Natl Acad Sci USA 102: 6015-20 (2005).
27. Nguyen HD, Hall CK. Molecular dynamics simulations of spontaneous fibril formation by random-coil peptides. Proc Natl Acad Sci USA 101: 16180-5 (2004).
28. Chen W, Mousseau N, Derreumaux P. The conformations of the amyloid-beta(21-30) fragment can be described by three families in solution. J Chem Phys 125: 084911 (2006).
29. Ding F, Buldyrev SV, Dokholyan NV. Folding Trp-cage to NMR resolution native structure using a coarse-grained protein model. Biophys J 88: 147-55 (2005).
30. Mousseau N, Derreumaux P, Barkema GT, Malek R. Sampling activated mechanisms in proteins with the activation-relaxation technique. J Mol Graph Model 19: 78-86 (2001).
31. Wei G, Mousseau N, Derreumaux P. Exploring the energy landscape of proteins: A characterization of the activation-relaxation technique. J Chem Phys 117: 11379-87 (2002).
32. Wei G, Derreumaux P, Mousseau N. Sampling the complex energy landscape of a simple β-hairpin. J Chem Phys 119: 6403-6 (2003).
33. Derreumaux P. A diffusion process-controlled Monte Carlo method for finding the global energy minimum of a polypeptide chain. I. Formulation, test on a hexadecapeptide. J Chem Phys 106: 5260-70 (1997).
34. Derreumaux P. Folding a 20 amino acid alpha-beta peptide with the diffusion process-controlled Monte Carlo method. J Chem Phys 107: 1941-7 (1997).
35. Derreumaux P. From polypeptide sequences to structures using Monte Carlo simulations, an optimized potential. J Chem Phys 111: 2301-10 (1999).
36. Derreumaux P. Generating ensemble averages for small proteins from extended conformations by Monte Carlo simulations. Phys Rev Lett 85: 206-9 (2000).
37. Malek R, Mousseau N. Dynamics of lennard-jones clusters: A characterization of the activation-relaxation technique. Phys Rev E 62: 7723-8 (2000).
38. Barkema GT, Mousseau N. Event-Based Relaxation of Continuous Disordered Systems. Phys Rev Lett 77: 4358-61 (1996).
39. Floquet N, Pasco S, Ramont L, Derreumaux P, Laronze JY, Nuzillard JM, et al. The antitumor properties of the alpha3(IV)-(185-203) peptide from the NC1 domain of type IV collagen (tumstatin) are conformation-dependent. J Biol Chem 279: 2091-100 (2004).
40. Derreumaux P. Insight into protein topology from Monte Carlo simulations. J Chem Phys 117: 3499-503 (2002).
41. Wei G, Mousseau N, Derreumaux P. Complex folding pathways in a simple beta-hairpin. Proteins 56: 464-74 (2004).
42. Santini S, Wei G, Mousseau N, Derreumaux P. Pathway complexity of Alzheimer's β-amyloid Aβ(16-22) peptide assembly. Structure 12: 1245-55 (2004).
43. Santini S, Mousseau M, Derreumaux P. In silico assembly of Alzheimer's Aβ(16-22) peptide into β-sheets. J Am Chem Soc 126: 11509-16 (2004).
44. Melquiond A, Mousseau N, Derreumaux P. Structures of soluble amyloid oligomers from computer simulations. Proteins 65: 180-191 (2006).
45. Petty SA, Decatur SM. Experimental evidence for the reorganization of beta-strands within aggregates of the Aβ(16-22) peptide. J Am Chem Soc 127: 13488-9 (2005).
46. Maupetit J, Tuffery P, Derreumaux P. A coarse-grained protein force field for folding, structure prediction. Proteins 69: 394-408 (2007).
47. Benzinger TL, Gregory DM, Burkoth TS, Miller-Auer H, Lynn DG, Botto RE, et al. Two-dimensional structure of β-amyloid(10-35) fibrils. Biochemistry 39: 3491-9 (2000).
48. Paravastu AK, Petkova AT, Tycko R. Polymorphic fibril formation by residues 10-40 of the Alzheimer's β-amyloid peptide. Biophys J 90: 4618-29 (2006).
49. Baumketner A, Shea JE. The structure of the Alzheimer amyloid beta 10-35 peptide probed through replica-exchange molecular dynamics simulations in explicit solvent. J Mol Biol 366: 275-85 (2007).
50. Tarus B, Straub JE, Thirumalai D. Dynamics of Asp23-Lys28 salt-bridge formation in Aβ10-35 monomers. J Am Chem Soc 128: 16159-68 (2006).
51. Zhang S, Iwata K, Lachenmann MJ, Peng JW, Li S, Stimson ER, et al. The Alzheimer's peptide Aβ adopts a collapsed coil structure in water. J Struct Biol 130: 130-41 (2000).
52. Han W, Wu YD. A strand-loop-strand structure is a possible intermediate in fibril elongation: long time simulations of amyloid-β peptide (10-35). J Am Chem Soc 127: 15408-16 (2005).
53. Xu Y, Shen J, Luo X, Zhu W, Chen K, Ma J, et al. Conformational transition of amyloid β-peptide. Proc Natl Acad Sci USA 102: 5403-7 (2005).
54. Flock D, Colacino S, Colombo G, Di Nola A. Misfolding of the amyloid β-protein: a molecular dynamics study. Proteins 62: 183-92 (2006).
55. Luttmann E, Fels G. All-atom molecular dynamic studies of the full-length β-amyloid peptides, Chem Phys 323: 138-47 (2006).
56. Tomaselli S, Esposito V, Vangone P, van Nuland NA, Bonvin AM, Guerrini R, et al. The alpha-to-beta conformational transition of Alzheimer's Aβ(1-42) peptide in aqueous media is reversible: a step by step conformational analysis suggests the location of beta conformation seeding. Chembiochem 7: 257-67 (2006).
57. Lam A, Urbanc B, Borreguero JM, Lazo ND, Teplow DB, Stanley HE. Discrete molecular dynamics study of Alzheimer Amyloid β-protein (Aβ) folding. Proceedings of the 2006 International Conference on Bioinformatics & Computational Biology pp 322-28 (2006). Editors Hamid R. Arabnia, Homayoun Valafar, CSREA Press (ISBN).
58. Raffa DF, Rauk A. Molecular dynamics study of the beta-amyloid peptide of Alzheimer's disease, its divalent copper complexes. J Phys Chem B 111: 3789-99 (2007).
59. Baumketner A, Bernstein SL, Wyttenbach T, Bitan G, Teplow DB, Bowers MT, et al. Amyloid beta-protein monomer structure: a computational, experimental study. Protein Sci 15: 420-8 (2006).
60. Sgourakis NG, Yan Y, McCallum SA, Wang C, Garcia AE. The Alzheimer's peptides Abeta40, 42 adopt distinct conformations in water: a combined MD / NMR study. J Mol Biol 368: 1448-57 (2007).
61. Lim KH, Collver HH, Le YT, Nagchowdhuri P, Kenney JM. Characterizations of distinct amyloidogenic conformations of the Abeta(1-40), (1-42) peptides. Biochem Biophys Re. Commun 353: 443-9 (2007).
62. Cleary JP, Walsh DM, Hofmeister JJ, Shankar GM, Kuskowski MA, Selkoe DJ, et al. Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci 8: 79-84 (2005).
63. Tarus B, Straub JE, Thirumalai D. Probing the initial stage of aggregation of the Abeta(10-35)-protein: assessing the propensity for peptide dimerization. J Mol Biol 345: 1141-56 (2005).
64. Jang S, Shin S. Amyloid beta-peptide oligomerization in silico: dimer, trimer. J Phys Chem B 110: 1955-8 (2006).
65. Urbanc B, Cruz L, Ding F, Sammond D, Khare S, Buldyrev SV, et al. Molecular dynamics simulation of amyloid beta dimer formation. Biophys J 87: 2310-21 (2004).
66. Huet A, Derreumaux P. Impact of the mutation A21G (Flemish variant) on Alzheimer's beta-amyloid dimers by molecular dynamics simulations. Biophys J 91: 3829-40 (2006).
67. Derreumaux P, Mousseau N. Coarse-grained protein molecular dynamics simulations. J Chem Phys 126: 025101 (2007).
68. Wei G, Song W, Derreumaux P, Mousseau N. Self-assembly of amyloid-forming peptides using molecular dynamics simulations, the OPEP coarse-grained force field. Front Biosci 13: 4517 (2008).
69. Tjernberg LO, Callaway DJ, Tjernberg A, Hahne S, Lilliehook C, Terenius L, et al. A molecular model of Alzheimer amyloid beta-peptide fibril formation. J Biol Chem 274: 12619-25 (1999).
70. Melquiond A, Gelly JC, Mousseau N, Derreumaux P. Probing amyloid fibril formation of the NFGAIL peptide by computer simulations. J Chem Phys 126: 065101 (2007).
71. Hou L, Kang I, Marchant RE, Zagorski MG. Methionine 35 oxidation reduces fibril assembly of the amyloid abeta-(1-42) peptide of Alzheimer's disease. J Biol Chem 277: 40173-6 (2002).
72. Kokkoni N, Stott K, Amijee H, Mason JM, Doig AJ. N-Methylated peptide inhibitors of beta-amyloid aggregation, toxicity: Optimization of the inhibitor structure. Biochemistry 45:9906-18 (2006).